Showing results (101-110 of 196) with videos related to
Sort By:
Pageof 20
Clinical Trials (London, England)|April 4, 2024
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project OptimusPeter F Thall, Elizabeth Garrett-Mayer, Nolan A Wages, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture systemPeter H Shaw, Devin Gilligan, Xue-Mei Wang, et al.Biometrics|January 24, 2018
A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroupsThomas A Murray, Ying Yuan, Peter F Thall, et al.The Annals of Applied Statistics|November 4, 2022
BAYESIAN HIERARCHICAL RANDOM-EFFECTS META-ANALYSIS AND DESIGN OF PHASE I CLINICAL TRIALSRuitao Lin, Haolun Shi, Guosheng Yin, et al.Clinical Trials (London, England)|September 3, 2014
Effective sample size for computing prior hyperparameters in Bayesian phase I-II dose-findingPeter F Thall, Richard C Herrick, Hoang Q Nguyen, et al.Blood|July 5, 2003
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AMLElihu H Estey, Peter F Thall, Xuemei Wang, et al.Statistics in Medicine|April 12, 2007
Bayesian and frequentist two-stage treatment strategies based on sequential failure times subject to interval censoringPeter F Thall, Leiko H Wooten, Christopher J Logothetis, et al.Biometrics|March 16, 2011
Optimizing the concentration and bolus of a drug delivered by continuous infusionPeter F Thall, Aniko Szabo, Hoang Q Nguyen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Novel Clinical Trial Designs with Dose Optimization to Improve Long-term OutcomesPeter F Thall, Yong Zang, Andrew G Chapple, et al.Current Opinion in Oncology|June 30, 2009
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemiaBorje S Andersson, Marcos de Lima, Peter F Thall, et al.Pageof 20